December 11, 2017 01:55 PM EST
Pharma

In lat­est blow to Eli Lil­ly, Sanofi wins FDA OK for Hu­ma­log me-too

Brittany Meiling

Sanofi $SNY got the green­light from FDA to sell its me-too in­sulin prod­uct Ad­mel­og, threat­en­ing mar­ket leader Eli Lil­ly’s $LLY block­buster sales in di­a­betes. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

A service from the Financial Times